img

Global Porcine Circovirus Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Circovirus Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Porcine circovirus (PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
The global Porcine Circovirus Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Porcine Circovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Porcine Circovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Porcine Circovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Porcine Circovirus Vaccine include Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology and Zoetis, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Porcine Circovirus Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Porcine Circovirus Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Porcine Circovirus Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Porcine Circovirus Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Merial
By Type
Genetic Engineering Vaccine
Killed Vaccines
By Application
Piglets
Adults Pigs
Sales by Region
North America
the United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Porcine Circovirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Porcine Circovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Circovirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Porcine Circovirus Vaccine Definition
1.2 Market by Type
1.2.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Genetic Engineering Vaccine
1.2.3 Killed Vaccines
1.3 Market Segment by Application
1.3.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Porcine Circovirus Vaccine Sales
2.1 Global Porcine Circovirus Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Porcine Circovirus Vaccine Revenue by Region
2.3.1 Global Porcine Circovirus Vaccine Revenue by Region (2018-2024)
2.3.2 Global Porcine Circovirus Vaccine Revenue by Region (2024-2034)
2.4 Global Porcine Circovirus Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Porcine Circovirus Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Porcine Circovirus Vaccine Sales Quantity by Region
2.6.1 Global Porcine Circovirus Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Porcine Circovirus Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Porcine Circovirus Vaccine Sales Quantity by Manufacturers
3.1.1 Global Porcine Circovirus Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Porcine Circovirus Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Porcine Circovirus Vaccine Sales in 2022
3.2 Global Porcine Circovirus Vaccine Revenue by Manufacturers
3.2.1 Global Porcine Circovirus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Circovirus Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Circovirus Vaccine Revenue in 2022
3.3 Global Porcine Circovirus Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Porcine Circovirus Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Circovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Circovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Circovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Circovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Porcine Circovirus Vaccine Sales Quantity by Type
4.1.1 Global Porcine Circovirus Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Porcine Circovirus Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Porcine Circovirus Vaccine Revenue by Type
4.2.1 Global Porcine Circovirus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Circovirus Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Porcine Circovirus Vaccine Price by Type
4.3.1 Global Porcine Circovirus Vaccine Price by Type (2018-2024)
4.3.2 Global Porcine Circovirus Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Porcine Circovirus Vaccine Sales Quantity by Application
5.1.1 Global Porcine Circovirus Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Porcine Circovirus Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Porcine Circovirus Vaccine Revenue by Application
5.2.1 Global Porcine Circovirus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Circovirus Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Porcine Circovirus Vaccine Price by Application
5.3.1 Global Porcine Circovirus Vaccine Price by Application (2018-2024)
5.3.2 Global Porcine Circovirus Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Porcine Circovirus Vaccine Sales by Company
6.1.1 North America Porcine Circovirus Vaccine Revenue by Company (2018-2024)
6.1.2 North America Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Porcine Circovirus Vaccine Market Size by Type
6.2.1 North America Porcine Circovirus Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Porcine Circovirus Vaccine Revenue by Type (2018-2034)
6.3 North America Porcine Circovirus Vaccine Market Size by Application
6.3.1 North America Porcine Circovirus Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Porcine Circovirus Vaccine Revenue by Application (2018-2034)
6.4 North America Porcine Circovirus Vaccine Market Size by Country
6.4.1 North America Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Porcine Circovirus Vaccine Revenue by Country (2018-2034)
6.4.3 North America Porcine Circovirus Vaccine Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Porcine Circovirus Vaccine Sales by Company
7.1.1 Europe Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Porcine Circovirus Vaccine Revenue by Company (2018-2024)
7.2 Europe Porcine Circovirus Vaccine Market Size by Type
7.2.1 Europe Porcine Circovirus Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Porcine Circovirus Vaccine Revenue by Type (2018-2034)
7.3 Europe Porcine Circovirus Vaccine Market Size by Application
7.3.1 Europe Porcine Circovirus Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Porcine Circovirus Vaccine Revenue by Application (2018-2034)
7.4 Europe Porcine Circovirus Vaccine Market Size by Country
7.4.1 Europe Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Porcine Circovirus Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Porcine Circovirus Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Porcine Circovirus Vaccine Sales by Company
8.1.1 China Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Porcine Circovirus Vaccine Revenue by Company (2018-2024)
8.2 China Porcine Circovirus Vaccine Market Size by Type
8.2.1 China Porcine Circovirus Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Porcine Circovirus Vaccine Revenue by Type (2018-2034)
8.3 China Porcine Circovirus Vaccine Market Size by Application
8.3.1 China Porcine Circovirus Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Porcine Circovirus Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Porcine Circovirus Vaccine Sales by Company
9.1.1 APAC Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Porcine Circovirus Vaccine Revenue by Company (2018-2024)
9.2 APAC Porcine Circovirus Vaccine Market Size by Type
9.2.1 APAC Porcine Circovirus Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Porcine Circovirus Vaccine Revenue by Type (2018-2034)
9.3 APAC Porcine Circovirus Vaccine Market Size by Application
9.3.1 APAC Porcine Circovirus Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Porcine Circovirus Vaccine Revenue by Application (2018-2034)
9.4 APAC Porcine Circovirus Vaccine Market Size by Region
9.4.1 APAC Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Porcine Circovirus Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Porcine Circovirus Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Porcine Circovirus Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Porcine Circovirus Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Chopper Biology
11.1.1 Chopper Biology Company Information
11.1.2 Chopper Biology Overview
11.1.3 Chopper Biology Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Chopper Biology Porcine Circovirus Vaccine Products and Services
11.1.5 Chopper Biology Porcine Circovirus Vaccine SWOT Analysis
11.1.6 Chopper Biology Recent Developments
11.2 ChengDu Tecbond
11.2.1 ChengDu Tecbond Company Information
11.2.2 ChengDu Tecbond Overview
11.2.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 ChengDu Tecbond Porcine Circovirus Vaccine Products and Services
11.2.5 ChengDu Tecbond Porcine Circovirus Vaccine SWOT Analysis
11.2.6 ChengDu Tecbond Recent Developments
11.3 Ringpu Biology
11.3.1 Ringpu Biology Company Information
11.3.2 Ringpu Biology Overview
11.3.3 Ringpu Biology Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Ringpu Biology Porcine Circovirus Vaccine Products and Services
11.3.5 Ringpu Biology Porcine Circovirus Vaccine SWOT Analysis
11.3.6 Ringpu Biology Recent Developments
11.4 Qilu Animal
11.4.1 Qilu Animal Company Information
11.4.2 Qilu Animal Overview
11.4.3 Qilu Animal Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Qilu Animal Porcine Circovirus Vaccine Products and Services
11.4.5 Qilu Animal Porcine Circovirus Vaccine SWOT Analysis
11.4.6 Qilu Animal Recent Developments
11.5 DHN
11.5.1 DHN Company Information
11.5.2 DHN Overview
11.5.3 DHN Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 DHN Porcine Circovirus Vaccine Products and Services
11.5.5 DHN Porcine Circovirus Vaccine SWOT Analysis
11.5.6 DHN Recent Developments
11.6 CAVAC
11.6.1 CAVAC Company Information
11.6.2 CAVAC Overview
11.6.3 CAVAC Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 CAVAC Porcine Circovirus Vaccine Products and Services
11.6.5 CAVAC Porcine Circovirus Vaccine SWOT Analysis
11.6.6 CAVAC Recent Developments
11.7 Komipharm
11.7.1 Komipharm Company Information
11.7.2 Komipharm Overview
11.7.3 Komipharm Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Komipharm Porcine Circovirus Vaccine Products and Services
11.7.5 Komipharm Porcine Circovirus Vaccine SWOT Analysis
11.7.6 Komipharm Recent Developments
11.8 Jinyu Bio-Technology
11.8.1 Jinyu Bio-Technology Company Information
11.8.2 Jinyu Bio-Technology Overview
11.8.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Products and Services
11.8.5 Jinyu Bio-Technology Porcine Circovirus Vaccine SWOT Analysis
11.8.6 Jinyu Bio-Technology Recent Developments
11.9 Zoetis
11.9.1 Zoetis Company Information
11.9.2 Zoetis Overview
11.9.3 Zoetis Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Zoetis Porcine Circovirus Vaccine Products and Services
11.9.5 Zoetis Porcine Circovirus Vaccine SWOT Analysis
11.9.6 Zoetis Recent Developments
11.10 Merial
11.10.1 Merial Company Information
11.10.2 Merial Overview
11.10.3 Merial Porcine Circovirus Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Merial Porcine Circovirus Vaccine Products and Services
11.10.5 Merial Porcine Circovirus Vaccine SWOT Analysis
11.10.6 Merial Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Porcine Circovirus Vaccine Value Chain Analysis
12.2 Porcine Circovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Circovirus Vaccine Production Mode & Process
12.4 Porcine Circovirus Vaccine Sales and Marketing
12.4.1 Porcine Circovirus Vaccine Sales Channels
12.4.2 Porcine Circovirus Vaccine Distributors
12.5 Porcine Circovirus Vaccine Customers
13 Market Dynamics
13.1 Porcine Circovirus Vaccine Industry Trends
13.2 Porcine Circovirus Vaccine Market Drivers
13.3 Porcine Circovirus Vaccine Market Challenges
13.4 Porcine Circovirus Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Genetic Engineering Vaccine
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Porcine Circovirus Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Porcine Circovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2018-2024)
Table 8. Global Porcine Circovirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2024-2034)
Table 10. Global Porcine Circovirus Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Porcine Circovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Porcine Circovirus Vaccine Sales Market Share by Region (2018-2024)
Table 13. Global Porcine Circovirus Vaccine Sales by Region (2024-2034) & (K Units)
Table 14. Global Porcine Circovirus Vaccine Sales Market Share by Region (2024-2034)
Table 15. Global Porcine Circovirus Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Porcine Circovirus Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Porcine Circovirus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Porcine Circovirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Porcine Circovirus Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Porcine Circovirus Vaccine, Industry Ranking, 2021 VS 2022
Table 21. Global Porcine Circovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Porcine Circovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Porcine Circovirus Vaccine as of 2022)
Table 23. Global Key Manufacturers of Porcine Circovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Porcine Circovirus Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Porcine Circovirus Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Porcine Circovirus Vaccine Sales Quantity Share by Type (2018-2024)
Table 30. Global Porcine Circovirus Vaccine Sales Quantity Share by Type (2024-2034)
Table 31. Global Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Porcine Circovirus Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Porcine Circovirus Vaccine Revenue Share by Type (2024-2034)
Table 35. Porcine Circovirus Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Porcine Circovirus Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Porcine Circovirus Vaccine Sales Quantity Share by Application (2018-2024)
Table 40. Global Porcine Circovirus Vaccine Sales Quantity Share by Application (2024-2034)
Table 41. Global Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Porcine Circovirus Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Porcine Circovirus Vaccine Revenue Share by Application (2024-2034)
Table 45. Porcine Circovirus Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Porcine Circovirus Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Porcine Circovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Porcine Circovirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Porcine Circovirus Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Porcine Circovirus Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Porcine Circovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Porcine Circovirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Porcine Circovirus Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Porcine Circovirus Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Porcine Circovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Porcine Circovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Porcine Circovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Porcine Circovirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Porcine Circovirus Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Porcine Circovirus Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Chopper Biology Company Information
Table 118. Chopper Biology Description and Overview
Table 119. Chopper Biology Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Chopper Biology Porcine Circovirus Vaccine Product and Services
Table 121. Chopper Biology Porcine Circovirus Vaccine SWOT Analysis
Table 122. Chopper Biology Recent Developments
Table 123. ChengDu Tecbond Company Information
Table 124. ChengDu Tecbond Description and Overview
Table 125. ChengDu Tecbond Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. ChengDu Tecbond Porcine Circovirus Vaccine Product and Services
Table 127. ChengDu Tecbond Porcine Circovirus Vaccine SWOT Analysis
Table 128. ChengDu Tecbond Recent Developments
Table 129. Ringpu Biology Company Information
Table 130. Ringpu Biology Description and Overview
Table 131. Ringpu Biology Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Ringpu Biology Porcine Circovirus Vaccine Product and Services
Table 133. Ringpu Biology Porcine Circovirus Vaccine SWOT Analysis
Table 134. Ringpu Biology Recent Developments
Table 135. Qilu Animal Company Information
Table 136. Qilu Animal Description and Overview
Table 137. Qilu Animal Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Qilu Animal Porcine Circovirus Vaccine Product and Services
Table 139. Qilu Animal Porcine Circovirus Vaccine SWOT Analysis
Table 140. Qilu Animal Recent Developments
Table 141. DHN Company Information
Table 142. DHN Description and Overview
Table 143. DHN Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. DHN Porcine Circovirus Vaccine Product and Services
Table 145. DHN Porcine Circovirus Vaccine SWOT Analysis
Table 146. DHN Recent Developments
Table 147. CAVAC Company Information
Table 148. CAVAC Description and Overview
Table 149. CAVAC Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. CAVAC Porcine Circovirus Vaccine Product and Services
Table 151. CAVAC Porcine Circovirus Vaccine SWOT Analysis
Table 152. CAVAC Recent Developments
Table 153. Komipharm Company Information
Table 154. Komipharm Description and Overview
Table 155. Komipharm Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Komipharm Porcine Circovirus Vaccine Product and Services
Table 157. Komipharm Porcine Circovirus Vaccine SWOT Analysis
Table 158. Komipharm Recent Developments
Table 159. Jinyu Bio-Technology Company Information
Table 160. Jinyu Bio-Technology Description and Overview
Table 161. Jinyu Bio-Technology Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Jinyu Bio-Technology Porcine Circovirus Vaccine Product and Services
Table 163. Jinyu Bio-Technology Porcine Circovirus Vaccine SWOT Analysis
Table 164. Jinyu Bio-Technology Recent Developments
Table 165. Zoetis Company Information
Table 166. Zoetis Description and Overview
Table 167. Zoetis Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Zoetis Porcine Circovirus Vaccine Product and Services
Table 169. Zoetis Porcine Circovirus Vaccine SWOT Analysis
Table 170. Zoetis Recent Developments
Table 171. Merial Company Information
Table 172. Merial Description and Overview
Table 173. Merial Porcine Circovirus Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Merial Porcine Circovirus Vaccine Product and Services
Table 175. Merial Porcine Circovirus Vaccine SWOT Analysis
Table 176. Merial Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Porcine Circovirus Vaccine Distributors List
Table 180. Porcine Circovirus Vaccine Customers List
Table 181. Porcine Circovirus Vaccine Market Trends
Table 182. Porcine Circovirus Vaccine Market Drivers
Table 183. Porcine Circovirus Vaccine Market Challenges
Table 184. Porcine Circovirus Vaccine Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Circovirus Vaccine Product Picture
Figure 2. Global Porcine Circovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Porcine Circovirus Vaccine Market Share by Type in 2022 & 2034
Figure 4. Genetic Engineering Vaccine Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Circovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Porcine Circovirus Vaccine Market Share by Application in 2022 & 2034
Figure 8. Piglets
Figure 9. Adults Pigs
Figure 10. Porcine Circovirus Vaccine Report Years Considered
Figure 11. Global Porcine Circovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Porcine Circovirus Vaccine Revenue 2018-2034 (US$ Million)
Figure 13. Global Porcine Circovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Porcine Circovirus Vaccine Sales Quantity 2018-2034 (K Units)
Figure 15. Global Porcine Circovirus Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Porcine Circovirus Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Porcine Circovirus Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Porcine Circovirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Porcine Circovirus Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Porcine Circovirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Porcine Circovirus Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Porcine Circovirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Porcine Circovirus Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Porcine Circovirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Porcine Circovirus Vaccine Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Porcine Circovirus Vaccine Revenue in 2022
Figure 29. Porcine Circovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 32. Global Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 34. North America Porcine Circovirus Vaccine Revenue Market Share by Company in 2022
Figure 35. North America Porcine Circovirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 36. North America Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 38. North America Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 40. North America Porcine Circovirus Vaccine Revenue Share by Country (2018-2034)
Figure 41. North America Porcine Circovirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 42. the United States Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Porcine Circovirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 45. Europe Porcine Circovirus Vaccine Revenue Market Share by Company in 2022
Figure 46. Europe Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 48. Europe Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 50. Europe Porcine Circovirus Vaccine Revenue Share by Country (2018-2034)
Figure 51. Europe Porcine Circovirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 53. France Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. UK Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. China Porcine Circovirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 58. China Porcine Circovirus Vaccine Revenue Market Share by Company in 2022
Figure 59. China Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 61. China Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 63. APAC Porcine Circovirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 64. APAC Porcine Circovirus Vaccine Revenue Market Share by Company in 2022
Figure 65. APAC Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 67. APAC Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 69. APAC Porcine Circovirus Vaccine Revenue Share by Region (2018-2034)
Figure 70. APAC Porcine Circovirus Vaccine Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. India Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Share by Country (2018-2034)
Figure 84. Brazil Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Porcine Circovirus Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Porcine Circovirus Vaccine Value Chain
Figure 90. Porcine Circovirus Vaccine Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed